Skip to content
Antiemetic & CIPN Guideline Updates episode artwork

Jul 23, 2020 15 min

Antiemetic & CIPN Guideline Updates

from OncoPharm Hosted by John Bossaer

We summarize the changes to ASCO's latest Antiemetic Guidelines update as well as their guidelines for chemotherapy-induced peripheral neuropathy (CIPN). Then, we take a look at the PO decitabine approval and ponder the question, does low albumin decrease tolerability to some TKIs?

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Antiemetic & CIPN Guideline Updates

0:00 15:02

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 15 minutes long.

When was this OncoPharm episode published?

This episode was published on July 23, 2020.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.